Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG33826

ANKRD16 Knockout jurkat Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Blood (peripheral blood)

  • Disease:

    Acute lymphoblastic leukemia (ALL)

The ANKRD16 Knockout Jurkat Polyclonal Cells are a CRISPR/Cas9-edited polyclonal T-cell population with disruption of the ANKRD16 gene, encoding an ankyrin repeat protein linked to ciliary trafficking and retinal disease. ANKRD16 interacts with IFT88, a core intraflagellar transport component, and this knockout model in a non-ciliated immune cell background enables investigation of cilia-independent functions. Ideal for protein interaction studies, immune cell signaling analysis, and CRISPR off-target screening, the cells support techniques such as co-immunoprecipitation, flow cytometry, and RT-qPCR. The product offers a versatile platform for exploring ankyrin repeat biology in a T-lymphocytic context.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Jurkat

    Cell Type

    T cell line

    Sex of Donor

    Male

    Age

    14 years

    Derived From Site

    In situ; Peripheral blood

    Gene Name

    ANKRD16

    Gene Identifier

    NCBI Gene ID 54522

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The ANKRD16 Knockout Jurkat Polyclonal Cells are a mixed population of Jurkat T lymphocytes engineered via CRISPR/Cas9 to disrupt the ANKRD16 gene, creating a loss-of-function model for studying ankyrin repeat domain-containing protein 16. This polyclonal knockout pool comprises cells with a range of gene-editing events, enabling bulk analysis of ANKRD16 deficiency without clonal selection. The product serves as a robust tool for functional genomics, protein interaction mapping, and immune cell biology investigations.

The Jurkat host cell line is an immortalized human T-lymphocyte line originally derived from a 14-year-old male with acute T-cell leukemia. Widely used as a model for T-cell receptor signaling, Jurkat cells recapitulate key aspects of T-cell activation, proliferation, and apoptosis. They provide a well-characterized system for probing signaling pathways relevant to immunology and leukemia biology, making them suitable for knockout studies aimed at uncovering novel regulators of T-cell function.

ANKRD16 encodes a protein containing ankyrin repeat motifs, which typically mediate protein-protein interactions. The protein is implicated in ciliary protein trafficking and photoreceptor homeostasis, with mutations leading to retinal dystrophies such as Leber congenital amaurosis and retinitis pigmentosa. ANKRD16 is reported to interact with IFT88, a core component of the intraflagellar transport complex essential for ciliary assembly and maintenance. Although Jurkat cells lack primary cilia, the knockout line provides a unique opportunity to explore cilia-independent roles of ANKRD16 in immune cell signaling and protein interaction networks.

In the context of Jurkat T cells, ANKRD16 deficiency may reveal novel functions beyond its established ciliary role. The polyclonal knockout population allows researchers to assess how loss of ANKRD16 affects T-cell receptor-mediated signaling, cytokine production, or proliferation, potentially uncovering adaptor-like functions mediated through ankyrin repeat domains. This model bridges the gap between ciliary biology and immunology, offering insights into the diverse functions of ankyrin repeat proteins in different cellular environments.

Typical applications include protein interaction studies via co-immunoprecipitation to confirm ANKRD16-IFT88 binding and identify new partners, functional analysis using flow cytometry for T-cell activation markers, and gene expression profiling by RT-qPCR. Western blotting and immunofluorescence enable validation of knockout efficiency and subcellular localization. Additionally, the polyclonal population is well-suited for CRISPR off-target analysis. This product accelerates research into ankyrin repeat protein biology and its implications in both ciliary and non-ciliary contexts. For further details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)